Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2014

Conditions
Primary Open Angle GlaucomaPseudoexfoliation Glaucoma
Interventions
DRUG

prednisolone 1%

eye drop once in each eye treated, 4 times / day for 5 days post-laser

DRUG

ketorolac 0.5%

eye drop once in each eye treated, 4 times / day for 5 days post-laser

DRUG

Artificial Tears (Methyl cellulose drops)

eye drop once in each eye treated, 4 times / day for 5 days post-laser

Trial Locations (1)

Unknown

Queen's University, Kingston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Glaucoma Research Society of Canada

OTHER

lead

Queen's University

OTHER

NCT00485108 - Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty | Biotech Hunter | Biotech Hunter